Technical considerations for acquiring and processing indium-111 capromab pendetide images

Journal of Nuclear Medicine Technology

Volumn 25, Issue 3, 1997, Pages 205-216

  Williams, Bonnie S ^a   Hinkle, George H ^a   Lamatrice, Renita A ^a   Fry, Jane P ^a   Loesch, James A ^a   Olsen, John O ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Indium 111 capromab pendetide; ProstaScint ; Prostate cancer

Indexed keywords

BISACODYL; ENEMA; INDIUM 111; ISPAGULA; MAGNESIUM CITRATE; MONOCLONAL ANTIBODY IN 111; RADIOPHARMACEUTICAL AGENT;

CATHETERIZATION; DIAGNOSTIC IMAGING; HUMAN; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; ORAL DRUG ADMINISTRATION; PELVIS; PROSTATE CANCER; QUALITY CONTROL; REVIEW; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; CATHARTICS; ENEMA; HUMANS; INDIUM RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030765609     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Parker SL, Tong T, Bolden S, et al. Cancer Statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Partin AW, Yoo J, Carter HB, et al. The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-114.
3. ProstaScint® package insert. Cytogen Corporation: Princeton, NJ; October 1996.
4. McNeal JE. The zonal anatomy of the prostate. Prostate 1981;2:35-49.
5. Perez CA, Fair WR, Ihde DC, et al. Chapter 29, cancer of prostate. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology, 2nd ed Philadelphia, PA: JB Lippincott Company; 1985.
6. Prout GR Jr, Heaney JA, Griffin PP, et al. Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol 1980;124:226-231.
7. Gervasi LA, Mata J, Easley JD, et al. Prognostic significance of lymph node metastases in prostate cancer. J Urol 1989;142:332-336.
8. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-935.
9. Wright GL Jr, Haley C, Beckett ML, et al. Expession of prostate-specific membrane antigen (PSMA) in normal, benign and malignant prostate tissues. Urol Oncology 1995;1:18-28.